시장보고서

상품코드

1455680

정밀종양학 시장 : 제품 유형별, 적응증별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Precision Oncology Market, By Product Type, By Indication Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 03월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 323 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

정밀종양학 시장 규모는 2023년 695억 8,467만 달러로 평가되었고, 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 11.2%로 확대될 것으로 예상됩니다.

정밀종양학 시장 - 시장 역학

기술 발전이 시장 수요를 촉진

시장 성장의 주요 촉진요인으로는 기술 발전, 효과적인 임상 결과를 가져와 치료 부작용을 최소화하고 약물 내성을 방지하는 진단 제품에 대한 수요 증가가 꼽힙니다. 마찬가지로, 연구 활동의 확대, 유방암의 조기 발견, 환자의 전반적인 예후는 정밀종양학에 대한 수요를 강화할 준비가 되어 있으며, 코로나19 팬데믹은 전 세계적으로 사회적 거리두기 및 폐쇄 조치로 인해 정밀종양학 시장에 영향을 미쳤습니다. 또한, 전염병의 초기 단계에서는 임상시험 연구가 일시적으로 중단되었습니다. 그러나 팬데믹 이후 병원 및 클리닉에서는 치료와 함께 정밀종양학 분석을 위한 환자 유입이 감소하고 있습니다. 정밀종양학 진단과 치료의 지연은 암 환자 치료에 큰 영향을 미치고 있습니다.

정밀종양학 시장 - 주요 인사이트

당사의 리서치 애널리스트들이 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 11.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 유형별로는 치료제가 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

적응증별로는 2023년 유방암이 주요 유형으로 부상할 것으로 예상됩니다.

지역별로는 북미가 2023년에 수익을 창출하는 주요 시장으로 꼽혔습니다.

정밀종양학 시장 - 세분화 분석 :

정밀종양학 세계 시장은 제품 유형, 적응증 유형, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 진단과 치료의 두 가지로 분류되며, 2023년에는 종양 진단 치료 승인 건수 증가와 암 성장을 가속하는 특정 단백질 및 돌연변이에 맞춘 치료제의 고유한 특성 등의 요인으로 인해 치료 분야가 시장 리더로 부상할 것으로 예상됩니다. 정밀종양학에 기반한 치료는 환자 개개인의 암 DNA 지문을 기반으로 환자 맞춤형 암 치료를 제공합니다.

이 시장은 적응증 유형에 따라 유방암, 대장암, 자궁경부암, 폐암, 전립선암, 기타 6가지로 분류되며, 2023년에는 유방암이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 유방암 검진 및 진단에 대한 관심 증가, 수술 및 방사선 기술의 발전으로 인한 것입니다. 또한, 연구 노력의 확대, 유방암의 조기 발견 및 환자 예후 개선은 정밀종양학과 같은 새로운 방법의 개발을 촉진할 것으로 예상됩니다. 또한 DNA 시퀀싱을 위한 첨단 기술의 출현은 유방암 환자 치료를 빠르게 발전시키고 있습니다.

정밀종양학 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다.

정밀종양학 시장 - 경쟁 상황 :

시장 내 정밀종양학 전문 기업들은 진단 도구, 분자 프로파일링 기술, 표적 치료의 혁신에 집중하여 암 치료 결과를 최적화하는 데 주력하고 있습니다. 이들 기업은 다양한 암종과 관련된 바이오마커와 유전자 변이를 식별하여 보다 정확한 진단과 치료법 선택을 가능하게 하는 연구개발에 자원을 투입하고 있습니다. 또한, 이들 기업은 의료진에게 종합적인 게놈 프로파일링 서비스를 제공하여 환자의 종양의 분자적 특성에 따라 정보에 입각한 치료 결정을 내릴 수 있도록 돕고 있습니다. 또한, 마케팅 이니셔티브는 종양 전문의, 의료 제공업체 및 환자들에게 치료 효과를 높이고 부작용을 최소화하며 궁극적으로 환자의 예후를 개선하는 정밀종양학의 이점에 대한 인식을 제고하기 위해 노력하고 있습니다. 정밀종양학 분야 시장 진출기업들은 시장에서의 입지를 강화하기 위해 계약, 신제품 출시, 사업 확장 등 다양한 혁신 전략을 추진하고 있습니다.

서론
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 정밀종양학 업계

경쟁 대시보드
기업 개요
- Thermo Fisher Scientific Inc.
- Invitae Corporation
- Qiagen NV
- Illumina, Inc.
- Laboratory Corporation Of America Holding
- Exact Sciences Corporation
- Rain Oncology Inc.
- Strata Oncology, Inc.
- Xilis, Inc.
- Variantyx, Inc.
- Bioserve
- Relay Therapeutics
- Acrivon Therapeutics
- Others

제12장 애널리스트의 전방위 전망

LSH 24.05.02

REPORT HIGHLIGHT

Precision Oncology Market size was valued at USD 69,584.67 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Precision oncology, also referred to as personalized or targeted cancer therapy, represents a tailored approach to cancer treatment, wherein medical interventions such as medications and treatment plans are customized to match the individual characteristics of each patient and their specific cancer subtype. This method considers various factors including the tumor's genetic makeup, molecular profile, and the patient's overall health, aiming to pinpoint the most effective treatment options with minimal side effects.

Precision Oncology Market- Market Dynamics

Technological advancements to propel market demand

Key drivers of market growth include technological advancements, a growing demand for diagnostic products delivering effective clinical results, thereby minimizing therapeutic side effects and preventing drug resistance. Similarly, expanding research activities, early detection of breast cancer, and overall patient prognosis are poised to bolster the demand for precision oncology. The COVID-19 pandemic has impacted the precision oncology market due to social distancing measures and lockdowns worldwide. Additionally, clinical trial studies were temporarily halted during the initial phase of the pandemic. However, post-pandemic, hospitals and clinics have experienced a decline in patient flow for precision oncology analysis along with therapeutic treatment. Delayed diagnosis and treatment using precision oncology have significantly affected cancer patient care.

Precision Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Product Type segmentation, therapeutics was predicted to show maximum market share in the year 2023

Based on Indication Type segmentation, breast cancer was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Oncology Market- Segmentation Analysis:

The Global Precision Oncology Market is segmented on the basis of Product Type, Indication Type, End Use, and Region.

The market is divided into two categories based on Product Type: diagnostics and therapeutics. In 2023, the therapeutics segment emerged as the market leader, propelled by factors such as the increasing amount of approvals for tumor-agnostic treatments and the unique characteristics of therapeutics tailored to specific proteins or mutations driving cancer growth. Precision oncology-based treatments offer patient-specific cancer treatment based on the DNA fingerprint of individually patient's cancer.

The market is divided into six categories based on Indication Type: breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and others. In 2023, breast cancer held the largest market share, attributed to the growing focus on breast cancer screening, diagnosis, and advancements in surgical and radiation techniques. Additionally, expanding research endeavors, early detection of breast cancer, and improved patient prognosis are expected to drive the development of novel methods like precision oncology. Furthermore, the advent of advanced technologies for DNA sequencing has rapidly advanced the treatment of breast cancer patients.

Precision Oncology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Precision Oncology Market- Competitive Landscape:

In the marketplace, companies specializing in precision oncology concentrate on innovating diagnostic tools, molecular profiling technologies, and targeted therapies to optimize cancer treatment outcomes. They allocate resources to research and development endeavors aimed at identifying biomarkers and genetic mutations associated with different cancer types, enabling more accurate diagnosis and treatment selection. Additionally, these companies may provide comprehensive genomic profiling services to healthcare providers, empowering them to make informed treatment decisions based on the molecular characteristics of the patient's tumor. Moreover, marketing initiatives seek to raise awareness among oncologists, healthcare providers, and patients regarding the benefits of precision oncology in enhancing treatment efficacy, minimizing adverse effects, and ultimately improving patient outcomes. Market players in the precision oncology sector are engaging in various innovative strategies such as agreements, new product launches, and expansions to bolster their market presence.

Recent Developments:

In December 2021, ConcertAI, LLC, along with LabCorp declared a collaboration aimed at enhancing precision oncology research. These companies are collaborating to launch clinical studies that will alleviate the burden on physician practices and improve patient retention, thereby ensuring equitable access to research as a care option and driving patient recruitment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Invitae Corporation

Qiagen N.V.

Illumina, Inc.

Laboratory Corporation Of America Holding

Exact Sciences Corporation

Rain Oncology Inc.

Strata Oncology, Inc.

Xilis, Inc.

Variantyx, Inc.

Bioserve

Relay Therapeutics

Acrivon Therapeutics

Others

GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

Diagnostics
Therapeutics

GLOBAL PRECISION ONCOLOGY MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others

GLOBAL PRECISION ONCOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

GLOBAL PRECISION ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Precision Oncology Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Precision Oncology Market Snippet by Product Type
- 2.1.2.Precision Oncology Market Snippet by Indication Type
- 2.1.3.Precision Oncology Market Snippet by End-Use
- 2.1.4.Precision Oncology Market Snippet by Country
- 2.1.5.Precision Oncology Market Snippet by Region
2.2.Competitive Insights

3.Precision Oncology Key Market Trends

3.1.Precision Oncology Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Precision Oncology Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Precision Oncology Market Opportunities
3.4.Precision Oncology Market Future Trends

4.Precision Oncology Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Precision Oncology Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Precision Oncology Market Landscape

6.1.Precision Oncology Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Precision Oncology Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Diagnostics
- 7.1.3.Therapeutics

8.Precision Oncology Market - By Indication Type

8.1.Overview
- 8.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
- 8.1.2.Breast Cancer
- 8.1.3.Colorectal Cancer
- 8.1.4.Cervical Cancer
- 8.1.5.Prostate Cancer
- 8.1.6.Lung Cancer
- 8.1.7.Others

9.Precision Oncology Market - By End-Use

9.1.Overview
- 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 9.1.2.Hospitals & Diagnostic Laboratories
- 9.1.3.Pharmaceutical & Biotechnology Companies
- 9.1.4.Healthcare Data Companies

10.Precision Oncology Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Precision Oncology Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Precision Oncology Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Precision Oncology Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Precision Oncology Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Precision Oncology Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Oncology Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.Thermo Fisher Scientific Inc.
- 11.2.2.Invitae Corporation
- 11.2.3.Qiagen N.V.
- 11.2.4.Illumina, Inc.
- 11.2.5.Laboratory Corporation Of America Holding
- 11.2.6.Exact Sciences Corporation
- 11.2.7.Rain Oncology Inc.
- 11.2.8.Strata Oncology, Inc.
- 11.2.9.Xilis, Inc.
- 11.2.10.Variantyx, Inc.
- 11.2.11.Bioserve
- 11.2.12.Relay Therapeutics
- 11.2.13.Acrivon Therapeutics
- 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us